Riskpilot← Back to searchSign inGet full accessLAB-TECH AS
ASActiveOrg 994674811Kolleveien 11A, 1397 NesøyaWholesale of pharmaceutical and medical goods · NACE 4646Est. 20091 employeeslab-tech.no
Revenue 2024
NOK 1,3M
-12% vs 2023
EBITDA margin
-27.7%
+7% vs 2023
Equity ratio
72.9%
Financial strength
Net profit 2024
NOK -281K
+9% vs 2023
| Revenue | NOK 1,3M | -12% |
| EBITDA | NOK -368K | +7% |
| Net profit | NOK -281K | +9% |
| Total assets | NOK 987K | +1% |
| Equity | NOK 720K | +0% |
| Employees | 1 | — |
Legal name
LAB-TECH AS
Org number
994674811
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
22. oktober 2009
Share capital
NOK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Selskapets virksomhet er salg av medisinsk laboratorieutstyr og andre produkter/tjenester som naturlig hører sammen med dette, herunder å delta på samlinger og messer hvor tilsvarende produkter finnes og faktiske og potensielle kunder kan tenkes å være tilstede. Selskapet vil også søke å støtte forskningsprosjekter samt være aktiv pådriver for produktutvikling der dette synes hensiktsmessig for selskapet.
Address
Kolleveien 11A, 1397 Nesøya
Website
lab-tech.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 3 991 | 6 400 | 5 693 | 5 569 | 7 859 | 7 798 | 8 977 | 6 095 | 6 083 | 6 335 | 5 104 | 4 327 | 1 062 | 1 511 | 1 328 |
| Staff expenses | −0 | −756 | −1 514 | −2 149 | −1 534 | −1 787 | −1 587 | −1 658 | −1 881 | −1 943 | −1 870 | −1 715 | −1 697 | −922 | −849 | −859 |
| EBITDA | −96 | 245 | 156 | −611 | 351 | 725 | 1 013 | 2 060 | 92 | 243 | 369 | −45 | −63 | −792 | −394 | −368 |
| Depreciation & amort. | −0 | −6 | −13 | −84 | −6 | −6 | −6 | −6 | −6 | −6 | −6 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −96 | 239 | 143 | −695 | 345 | 719 | 1 007 | 2 054 | 86 | 237 | 362 | −45 | −63 | −792 | −394 | −368 |
| Net financials | 0 | −8 | 36 | −87 | −2 | 14 | 20 | 9 | 7 | 2 | 6 | 12 | 1 | 1 | −0 | 8 |
| Profit before tax | −96 | 231 | 179 | −781 | 342 | 734 | 1 027 | 2 063 | 93 | 239 | 368 | −33 | −62 | −791 | −394 | −360 |
| Tax | −28 | 65 | 50 | −219 | 100 | 198 | 278 | 517 | 23 | 55 | 81 | −7 | −0 | −188 | −87 | −79 |
| Net profit | −67 | 166 | 129 | −563 | 243 | 536 | 748 | 1 546 | 70 | 184 | 287 | −26 | −62 | −603 | −307 | −281 |
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 88 | 1 318 | 1 718 | 1 435 | 1 630 | 2 339 | 3 490 | 3 665 | 1 710 | 1 967 | 2 072 | 1 438 | 1 486 | 1 180 | 974 | 987 |
| Equity | — | 199 | 328 | −235 | 358 | 893 | 542 | 238 | 307 | 458 | 746 | 720 | 658 | 720 | 720 | 720 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 14 | 10 | 7 | 7 | 5 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 55 | 917 | 1 372 | 1 670 | 1 272 | 1 432 | 2 939 | 3 420 | 1 396 | 1 504 | 1 326 | 719 | 828 | 460 | 254 | 267 |
| Total debt | 55 | 1 119 | 1 391 | 1 670 | 1 272 | 1 445 | 2 949 | 3 427 | 1 403 | 1 509 | 1 326 | 719 | 828 | 460 | 254 | 267 |
EBITDA margin
-27.7%
This company
15.8%
Market median
-275% vs market
20092024
Equity ratio
72.9%
This company
38.2%
Market median
+91% vs market
20092024
Return on equity
-39.0%
This company
18.4%
Market median
-312% vs market
20092024
Net profit margin
-21.1%
This company
8.1%
Market median
-360% vs market
20092024
Asset turnover
1.35×
This company
1.12×
Market median
+21% vs market
20092024
Debt / equity
0.37×
This company
0.62×
Market median
+40% vs market
20092024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KG Deputy Member | Deputy Member | 2009 | — | — |
MR Chief Executive Officer | Chief Executive Officer | 2009 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Eufori As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Eufori As
LAB-TECH AS Board members of LAB-TECH AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kirsti Gunvor Nereng | Deputy Member | 0 companies |
| Mona Røseth | Chief Executive Officer | 0 companies |